Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Therapeutics is a biotechnology company focused on developing CRISPR-based gene editing therapies to transform lives of people with severe diseases. At Intellia, we are humbled to have a hand in making what we
-
-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything
-
to produce similar ‘carbon-capture’ plants using gene-editing technology. Please apply for this project using this link: https://www.sheffield.ac.uk/postgraduate/phd/apply/applying Funding Notes Open to Self
-
oncology research or functional genomics. Strong expertise in cell culture, molecular biology, and assay development. Experience with CRISPR-based gene editing and functional screening. Experience with RNAi
-
culture, cell phenotyping, sequencing, gene editing, and the isolation and characterization of extracellular vesicles is desired. Proficiency in bioinformatics tools and programming languages (e.g., R
-
: Send to ljhazen@stanford.edu (link sends e-mail) with subject line "Postdoctoral Applicant: Pioneering Gene Editing in Marine Organisms" Does this position pay above the required minimum
-
drug development, gene therapy and somatic cell genome editing, in vivo imaging, and innate immunity. Collaborations are fostered through the activities of affiliated programs such as the UC Davis
-
thinking skills. Experience with CRISPR-based functional genomics and gene-editing technologies. Proficiency in multi-omics data analysis (genomics, transcriptomics, proteomics), with experience in flow
-
candidates will join a group of supportive colleagues who conduct research across diverse disciplines, including cell signaling and growth control, gene expression and ‘omics approaches to cancer and age
-
functional genomics at the time employment begins. We are seeking candidates who apply state-of-the-art experimental techniques, such as microarrays, next-generation sequencing, and CRISPR-based gene editing